10x Genomics, Inc. Class A Common Stock (TXG) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for TXG. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 378 institutions reported holding TXG, with 128.3 million shares worth $4.9 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| FMR | 17,629,266 | $676M | DECREASED |
| Vanguard | 13,112,197 | $503M | DECREASED |
| BlackRock | 10,804,070 | $414M | INCREASED |
| ARK Invest | 10,003,057 | $384M | DECREASED |
| T. Rowe Price | 5,805,961 | $223M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Shehnaaz Suliman (Director) | SELL | 1,222 | $101K | 2026-09-22 |
| Shehnaaz Suliman (Director) | SELL | 2,270 | $185K | 2026-09-22 |
| Shehnaaz Suliman (Director) | SELL | 1,325 | $107K | 2026-09-22 |
| Shehnaaz Suliman (Director) | SELL | 614 | $49K | 2026-09-22 |
| Shehnaaz Suliman (Director) | SELL | 292 | $23K | 2026-09-22 |
Full institutional holdings, insider history, and congressional trades for 10x Genomics, Inc. Class A Common Stock on SentiSense.